T0	Participants 112 160	patients with lymphoma and resolved hepatitis B.
T1	Participants 294 341	patients with lymphoma and resolved hepatitis B
T2	Participants 375 437	Eighty patients with CD20(+) lymphoma and resolved hepatitis B
T3	Participants 780 800	Fifty-eight patients
T4	Participants 951 962	one patient
T5	Participants 1004 1018	seven patients
T6	Participants 1216 1229	control group
T7	Participants 1294 1307	Four patients
T8	Participants 1517 1530	control group
T9	Participants 1935 1983	patients with lymphoma and resolved hepatitis B.